715 ICT01 plus low dose SC IL-2 produces a robust anti-tumor immune activation in advanced cancer patients (EVICTION-2 Study) von Bono, Johann De, Champiat, Stéphane, Danlos, Francois-Xavier, Wermke, Martin, Kunzmann, Volker, Gassart, Aude De, Valentin, Emmanuel, Iche, Marina, Leparquier, Celine, Mairesse, Maelle, Brune, Patrick, Lemmens, Katrien, Olive, Daniel, Frohna, Paul

Volltext

A Multicenter Randomized Phase IIb Efficacy Study of Vx-001, a Peptide-Based Cancer Vaccine as Maintenance Treatment in Advanced Non–Small-Cell Lung Cancer: Treatment Rationale and... von Georgoulias, Vassilis, Douillard, Jean-Yves, Khayat, David, Manegold, Christian, Rosell, Rafael, Rossi, Antonio, Menez-Jamet, Jeanne, Iché, Marina, Kosmatopoulos, Kostas, Gridelli, Cesare

Volltext

Evaluation of ICT01, a γ9δ2 T Cell-Activating Monoclonal Antibody, Combined with Venetoclax and Azacitidine in 1L AML (EVICTION Study) von Wieduwild, Elisabeth, Le Floch, Anne-Charlotte, Garulli, Céline, Imbert, Caroline, De Gassart, Aude, Brune, Patrick, Lemmens, Katrien, Garciaz, Sylvain, Maiti, Abhishek, Peterlin, Pierre, Leparquier, Celine, Iche, Marina, Vey, Norbert, Olive, Daniel, Frohna, Paul

Volltext

Abstract CT034: Activation of the antitumor immune response of gamma9delta2 T cells in patients with solid or hematologic malignancies with ICT01, a first-in-class, monoclonal anti... von Marabelle, Aurelien, Jungels, Christiane, De Bono, Johann, Vey, Norbert, Wermke, Martin, Garralda, Elena, Gouill, Steven Le, LoRusso, Patricia, De Gassart, Aude, Valentin, Emmanuel, Brune, Patrick, Iche, Marina, Olive, Daniel, Frohna, Paul A.

Volltext

Abstract CT179: First-in-human study of ICT01, an anti-BTN3A activating monoclonal antibody in combination with low dose IL-2 in patients with advanced solid tumors (EVICTION-2 stu... von de Bono, Johann, Champiat, Stéphane, Danlos, Francois-Xavier, Wermke, Martin, Kunzmann, Volker, De Gassart, Aude, Valentin, Emmanuel, Iche, Marina, Mairesse, Maelle, Brune, Patrick, Lemmens, Katrien, Marabelle, Aurélien, Olive, Daniel, Frohna, Paul

Volltext

316 EVICTION Study: Preliminary results in solid tumor patients with ICT01, a first-in-class, gamma9 delta2 T cell activating antibody targeting butyrophilin-3A von Marabelle, Aurelien, Jungels, Christiane, Bono, Johann De, Vey, Norbert, Wermke, Martin, Garralda, Elena, Gassart, Aude de, Brune, Patrick, Valentin, Emmanuel, Iché, Marina, Olive, Daniel, Frohna, Paul

Volltext

Abstract CT188: ICT01, an anti-butyrophilin 3A targeted mAb activating g9d2 T cells, induces immune remodeling of the tumor microenvironment and clinical responses in combination w... von Champiat, Stephane, Wermke, Martin, de Bono, Johann, Marabelle, Aurelien, Jungels, Christiane, Vicier, Cécile, Vey, Norbert, List, Catrin, Wetzko, Katrin, Ruhnke, Leo, Garralda, Elena, de Aguiar, Vladimir Galvão, LoRusso, Patricia, Kotecki, Nuria, De Gassart, Aude, Valentin, Emmanuel, Brune, Patrick, Iché, Marina, Leparquier, Céline, Olive, Daniel, Frohna, Paul

Volltext